Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study
Authors
Keywords
-
Journal
CTS-Clinical and Translational Science
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-03
DOI
10.1111/cts.12881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia
- (2020) Feng Pan et al. RADIOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
- (2020) Lisheng Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
- (2020) Alfonso J. Rodriguez-Morales et al. Travel Medicine and Infectious Disease
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection
- (2019) Naoko Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes
- (2019) Hannah Limburg et al. JOURNAL OF VIROLOGY
- TMPRSS2 Is a Host Factor That Is Essential for Pneumotropism and Pathogenicity of H7N9 Influenza A Virus in Mice
- (2014) C. Tarnow et al. JOURNAL OF VIROLOGY
- The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses
- (2014) K. Sakai et al. JOURNAL OF VIROLOGY
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
- (2014) J. M. Lucas et al. Cancer Discovery
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
- (2013) Bastian Hatesuer et al. PLoS Pathogens
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started